Ca-rezz - Norisc - Incontinent Wash Solution
NDC Package 60762-113-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Ca-rezz - Norisc - Incontinent Wash (benzethonium chloride) solution is sPRAY CA-REZZ NORSIC WASH WHERE URINE, FECES OR EMESIS HAS SOILED SKIN PAD LINENS AND CLOTHING.REMOVE BULK OF FECES OR EMESIS.SPRAY ADDITIONAL CA-REZZ NORSIC WASH ON WARM WET CLOTH. This formulation utilizes a solution delivery system. Marketed by Fnc Medical Corporation, this product is identified by NDC 60762-113 and is authorized under FDA application M003.

Identification & Billing

NDC Package Code
60762-113-08
Package Description
237 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
60762011308
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
237 ML
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Ca-rezz - Norisc - Incontinent Wash
Non-Proprietary Name
Benzethonium Chloride
Substance Name
Benzethonium Chloride
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
SPRAY CA-REZZ NORSIC WASH WHERE URINE, FECES OR EMESIS HAS SOILED SKIN PAD LINENS AND CLOTHING.REMOVE BULK OF FECES OR EMESIS.SPRAY ADDITIONAL CA-REZZ NORSIC WASH ON WARM WET CLOTH. CLEANSE SKIN OF ALL REMAINING RESIDUE. PAT DRY. NOTE: IF AREA NEEDING CARE IS SIZEABLE AND FECAL OR EMESIS MATERIAL MASSIVE, RINSING IS ADVISED.ADD ONE CAPFUL OF CA-REZZ NORSIC WASH TO THE REGULAR LAUNDRY TO ELIMINATE RESIDUAL ODORS.

Regulatory & Marketing

Labeler Name
Fnc Medical Corporation
Product Type
Human Otc Drug
FDA Application #
M003
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-05-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60762-113-08 identifies a specific commercial package of 237 ml in 1 bottle, spray of Ca-rezz - Norisc - Incontinent Wash, a human over the counter drug labeled by Fnc Medical Corporation. This product is billed per "ML" milliliter and contains an estimated amount of 237 billable units per package. This solution is formulated for topical use and contains benzethonium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Fnc Medical Corporation on February 05, 2018. The current certification is valid through December 31, 2026.

How is this Fnc Medical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60762011308. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 237 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60762-113-08
11-Digit CMS (5-4-2)
60762-0113-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.